Globeflex Capital’s Edwards Lifesciences EW Stock Holding History

Globeflex Capital’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$161K	Hold	2,015	–	–	0.02%	319
2025 Q4	$172K	Hold	2,015	–	–	0.03%	321
2025 Q3	$157K	Hold	2,015	–	–	0.02%	327
2025 Q2	$158K	Hold	2,015	–	–	0.01%	334
2025 Q1	$146K	Buy	+2,015	New	+$144K	0.01%	335
2021 Q4	–	Sell	-27	Closed	-$3K	–	473
2021 Q3	$3K	Hold	27	–	–	﹤0.01%	428
2021 Q2	$3K	Hold	27	–	–	﹤0.01%	435
2021 Q1	$2K	Hold	27	–	–	﹤0.01%	440
2020 Q4	$2K	Hold	27	–	–	﹤0.01%	455
2020 Q3	$2K	Hold	27	–	–	﹤0.01%	450
2020 Q2	$2K	Hold	27	–	–	﹤0.01%	474
2020 Q1	$2K	Hold	27	–	–	﹤0.01%	478
2019 Q4	$2K	Hold	27	–	–	﹤0.01%	482
2019 Q3	$2K	Hold	27	–	–	﹤0.01%	469
2019 Q2	$2K	Buy	+27	New	+$1.63K	﹤0.01%	458
2017 Q3	–	Sell	-12,504	Closed	-$493K	–	404
2017 Q2	$493K	Hold	12,504	–	–	0.12%	245
2017 Q1	$392K	Hold	12,504	–	–	0.09%	300
2016 Q4	$391K	Hold	12,504	–	–	0.1%	290
2016 Q3	$502K	Buy	+12,504	New	+$471K	0.13%	248

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Globeflex Capital's EW Position: Q1 2026 in Review

Globeflex Capital held its Edwards Lifesciences (EW) position steady in Q1 2026 at 2,015 shares worth $161K. The position accounts for 0.02% of the portfolio, ranked #319.

Globeflex Capital first reported a position in EW in Q3 2016 and has held it in 19 quarters since. The position peaked at $502K in Q3 2016. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Globeflex Capital held 2,015 shares of Edwards Lifesciences worth $161K as of Q1 2026.
Globeflex Capital left its Edwards Lifesciences share count unchanged in Q1 2026.
Edwards Lifesciences made up 0.02% of Globeflex Capital's portfolio in Q1 2026, its #319 holding.
Globeflex Capital first reported a position in Edwards Lifesciences in Q3 2016 and has held it in 19 quarters since.
Globeflex Capital's Edwards Lifesciences position peaked at $502K in Q3 2016.
1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Globeflex Capital's 13F filing for Q1 2026, filed 13 May 2026.